Asier Unciti-Broceta
Innovative Therapeutics
Research in a Nutshell
The Innovative Therapeutics Lab is led by Professor Asier Unciti-Broceta and based at the CRUK Edinburgh Centre, part of the MRC Institute of Genetics and Molecular Medicine at the University of Edinburgh, where Asier established the first chemistry lab of the Institute in 2010. The lab explores novel chemical strategies to improve the efficacy and safety of cancer treatments. This includes development of highly-selective inhibitors of kinases involved in cancer and novel prodrug strategies aimed at improving the clinical use of well-established chemotherapy drugs.
People |
|
|
Principal Investigator and Professor of Medicinal Chemistry |
|
| Belen Rubio-Ruiz | Marie Curie Postdoctoral Fellow |
| Ana Perez-Lopez |
EPSRC Postdoctoral Fellow |
| Catherine Adam |
CRUK Postdoctoral Fellow |
| Teresa Valero-Griñan |
Marie Curie Postdoctoral Fellow |
| Carolin Temps |
PhD student |
| Daniel Baillache |
PhD student |
| Cecilia Ayala | PhD student |
Contact
Collaborations
-
Professor Neil Carragher (ECRC)
-
Dr Liz Patton (ECRC)
- Professor Val Brunton (ECRC)
- Professor Margaret Frame (ECRC)
- Professor H. Leung (Beatson Institute / University of Glasgow)
- Dr P. Brennan (Centre for Clinical Brain Sciences / University of Edinburgh)
- Dr D. Sieger (Centre for Neuroregeneration / University of Edinburgh)
- Dr C. Torres-Sánchez (Loughborough University)
- Dr R. Sanchez-Martín and Dr J. J. Díaz-Mochón (GENyO / Spain)
- Professor I. Molina (University of Granada / Spain)
Scientific Themes
Anticancer Therapy, Kinase Inhibitors, Bioorthogonal Prodrugs, Palladium Implants, Nanotechnology
Technology Expertise
Small Molecule Synthesis and Peptides, Medicinal Chemistry, Design and Development of Prodrugs, Target ID and Imaging Tools, Heterogeneous Catalysts